NCT07635784 Prospective HemorrhoIdaL EmboliSation (PILES) Registry
| NCT ID | NCT07635784 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Joint & Vascular Institute |
| Condition | Hemorrhoid |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2026-01-18 |
| Primary Completion | 2031-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2026-01-18 with a primary completion date of 2031-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of hemorrhoid artery embolization (HAE) for symptomatic bleeding internal hemorrhoids in adults aged 18 years or older that have not responded to medical therapy. The main question it aims to answer are: 1\) Does HAE lead to sustained improvement in bleeding (HDSS scores over 12-36 months? Participants will: * Undergo HAE as part of their routine clinical care. * Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires. * Have safety outcomes tracked according to Society of Interventional Radiology guidelines. There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.
Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years) with symptomatic bleeding internal hemorrhoids refractory to medical therapy, referred for HAE. Exclusion Criteria: * Pregnancy, coagulopathy, severe comorbidities, or inability to consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07635784 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemorrhoid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07635784 currently recruiting?
Yes, NCT07635784 is actively recruiting participants. Contact the research team at lalkhani@jointvascular.com for enrollment information.
Where is the NCT07635784 trial being conducted?
This trial is being conducted at Libertyville, United States.
Who is sponsoring the NCT07635784 clinical trial?
NCT07635784 is sponsored by Joint & Vascular Institute. The trial plans to enroll 1,200 participants.